That's what British company Owlstone, Inc. is trying to prove. They've developed something they call a breath biopsy, where a patient breaths into a special device for 10 minutes to trap metabolism byproducts called volatile organic compounds, or VOCs. Those trapped VOCs are analyzed in the Owlstone lab, looking for subtle differences that forma a kind of cancer fingerprint.
Yilokho inkampani yaseBrithani i-Owlstone, Inc. ezama ukukufakazela. Basungule okuthile okubizwa ngokuthi ibhayopsi yokuphefumula, lapho isiguli siphefumulela kudivayisi ekhethekile imizuzu engu-10 ukuze kubanjwe okukhiqizwa ukugayeka kokudla okubizwa ngokuthi yi-volatile organic compounds, noma ama-VOC. La ma-VOC abambekile ahlaziywa elebhu yase-Owlstone, kubhekwe umehluko onganakekile odala uphawu lohlobo lomdlavuza.